Inhibikase Therapeutics Inc (IKT)

CapEx to Revenue

0.00%

Quarterly · Period ending:

IKT logo

IKT CapEx to Revenue

Latest reported0.00%
IKT Quarterly CapEx/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

IKT capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
12.2309%
0%
0%
2,745.3847%
657.6313%
0.0065%
0.1543%
0.0006%
0.0003%
0%
0%
0%
0.0005%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.